[ad_1]
The COVID-19 vaccine developed by the American pharmaceutical giant Pfizer and the German biotechnology company BioNTech has shown an efficiency of 95%. These are the final results of the clinical trials.
The Wall Street Journal reported.
The company is preparing to request the vaccination registry in the next few days. The developers noted that this vaccine proved highly effective against coronavirus 28 days after the first dose. Its efficacy was the same for all ages and ethnic groups.
In older volunteers, the vaccine is more than 94% effective.
We will recall, earlier, the Chief Medical Officer Viktor Lyashko said that Ukraine will receive around 8.5 million doses of COVID-19 vaccine.
It was also reported that Ukraine will be offered a special price for the COVID-19 vaccine.
It was previously known about the successful vaccine trials of the pharmaceutical companies Pfizer and BioNTech. The manufacturer has already promised a price below market value.
As noted, this vaccine will go on sale shortly. She has not yet received regulatory approval, in addition, access to a wide range of people will be limited by special storage conditions.
